Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
Sanofi
Haukeland University Hospital
University of Pittsburgh
Karyopharm Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)